Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease.

Kim HJ, Hong SJ, Jeon YW, Han JP, Han SH, Kang JH, Tae JW, Lim HS, Kim HK, Ko BM, Lee MS.

Clin Endosc. 2013 Jan;46(1):71-6. doi: 10.5946/ce.2013.46.1.71. Epub 2013 Jan 31.

2.

Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.

Jahnsen J, Falch JA, Mowinckel P, Aadland E.

Scand J Gastroenterol. 2004 Feb;39(2):145-53.

PMID:
15000276
3.

Femoral neck osteopenia in patients with inflammatory bowel disease.

Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.

Am J Gastroenterol. 1998 Sep;93(9):1483-90.

PMID:
9732930
4.

Bone mineral density in Iranian patients with inflammatory bowel disease.

Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B, Sayyah A, Bashashati M, Jazayeri H, Zand S.

Int J Colorectal Dis. 2006 Dec;21(8):758-66. Epub 2006 Feb 4.

PMID:
16463035
5.

Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease.

Lopes LH, Sdepanian VL, Szejnfeld VL, de Morais MB, Fagundes-Neto U.

Dig Dis Sci. 2008 Oct;53(10):2746-53. doi: 10.1007/s10620-008-0223-0. Epub 2008 Mar 20.

PMID:
18351466
6.

Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.

Koutroubakis IE, Zavos C, Damilakis J, Papadakis G, Neratzoulakis J, Karkavitsas N, Kouroumalis EA.

J Clin Gastroenterol. 2011 Jul;45(6):e60-5. doi: 10.1097/MCG.0b013e3181f42543.

PMID:
20921904
7.

[Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].

Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A.

Gastroenterol Clin Biol. 2003 Oct;27(10):901-7. French.

8.
9.

Bone mineral density assessment in children with inflammatory bowel disease.

Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS.

Gastroenterology. 1998 May;114(5):902-11.

PMID:
9558278
10.

[Bone metabolism changes in 100 patients with inflammatory bowel disease].

Legido J, Gisbert JP, Maté J.

Gastroenterol Hepatol. 2011 Jun-Jul;34(6):379-84. doi: 10.1016/j.gastrohep.2011.03.019. Epub 2011 Jun 12. Spanish.

PMID:
21664725
11.

Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.

Nemetz A, Tóth M, García-González MA, Zágoni T, Fehér J, Peña AS, Tulassay Z.

Gut. 2001 Nov;49(5):644-9.

12.

[Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].

Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M.

Z Gastroenterol. 1999 Jan;37(1):5-12. German.

PMID:
10091278
13.

Bone mineral density in patients with inflammatory bowel disease.

Martin JP, Tonge KA, Bhonsle U, Jacyna MR, Levi J.

Eur J Gastroenterol Hepatol. 1999 May;11(5):537-41.

PMID:
10755258
14.

Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.

Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D.

Am J Gastroenterol. 2000 Mar;95(3):699-704.

PMID:
10710060
15.

Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.

Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M.

Osteoporos Int. 2004 Nov;15(11):855-61. Epub 2004 Mar 18.

PMID:
15034643
16.

Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.

Palomba S, Orio F Jr, Manguso F, Falbo A, Russo T, Tolino A, Tauchmanovà L, Colao A, Doldo P, Mastrantonio P, Zullo F.

Osteoporos Int. 2005 Sep;16(9):1141-9. Epub 2005 Jun 1.

PMID:
15928801
17.

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.

Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.

Am J Med. 1996 Sep;101(3):262-9.

PMID:
8873487
18.

Bone density improves with disease remission in patients with inflammatory bowel disease.

Reffitt DM, Meenan J, Sanderson JD, Jugdaohsingh R, Powell JJ, Thompson RP.

Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1267-73.

PMID:
14624148
19.

Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease.

Schmidt S, Mellström D, Norjavaara E, Sundh V, Saalman R.

J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):511-8. doi: 10.1097/MPG.0b013e31825817a0.

PMID:
22688562
20.

Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.

Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G.

J Intern Med. 2000 Jan;247(1):63-70.

Supplemental Content

Support Center